Sen. Bob Menendez’s Opposition to Drug Pricing Reform May Imperil the Democratic Agenda
The New Jersey Democrat refuses to say whether his aversion to Medicare drug bargaining will turn him against the reconciliation bill.
The New Jersey Democrat refuses to say whether his aversion to Medicare drug bargaining will turn him against the reconciliation bill.
A lawyer with Gibson Dunn, a firm hired by Chevron, was a major fundraiser for Gillibrand, who has been silent on Donziger’s case.
As the two countries meet this week to discuss security cooperation, lawmakers see the sale as evidence of a systemic problem.
Voices
Crushing the tax haven racket is a big political challenge, but the steps needed are straightforward and simple.
The Coronavirus Crisis
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.
The proposed $3.5 trillion for the Build Back Better agenda is much, much less money than you think — but don't expect the corporate media to tell you that.
The naval agency investigated at least eight sexual offenses between 2017 and 2019. None of them were reported to Congress or the public.
The progressive flex was a long time coming.
The End of Roe
There are two pathways to Medicaid expansion on the table — but both need the reconciliation package to make it through.
Origins of Covid
The unusual timing of a bat coronavirus grant report suggests that an earlier version may have been revised.
This is not a paywall.
By signing up, I agree to receive emails from The Intercept and to the Privacy Policy and Terms of Use.